Interest Expense in USD of Galera Therapeutics, Inc. from 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Galera Therapeutics, Inc. quarterly/annual Interest Expense history and change rate from 2018 to Q3 2025.
  • Galera Therapeutics, Inc. Interest Expense for the quarter ending 30 Sep 2025 was $0.000.
  • Galera Therapeutics, Inc. annual Interest Expense for 2024 was $0.000, a 100% decline from 2023.
  • Galera Therapeutics, Inc. annual Interest Expense for 2023 was $11.4M, a 1.36% decline from 2022.
  • Galera Therapeutics, Inc. annual Interest Expense for 2022 was $11.6M, a 60.8% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Galera Therapeutics, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 $0 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q4 2024 $0 $0 -$705K -100% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 $705K $0 -$2.09M -100% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 $2.79M $0 -$4.4M -100% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $7.19M $0 -$4.22M -100% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024
Q4 2023 $11.4M $705K -$2.62M -78.8% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 $14M $2.09M -$1.16M -35.7% 01 Jul 2023 30 Sep 2023 10-Q 13 Dec 2024
Q2 2023 $15.2M $4.4M +$1.7M +63% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 $13.5M $4.22M +$1.92M +83.4% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 $11.6M $3.32M +$1.01M +43.8% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $10.6M $3.25M +$918K +39.5% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $9.64M $2.7M +$1.4M +107% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $8.24M $2.3M +$1.05M +83.8% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $7.19M $2.31M +$1.06M +84.2% 01 Oct 2021 31 Dec 2021 10-K 08 Mar 2023
Q3 2021 $6.14M $2.33M +$1.09M +88.4% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $5.05M $1.3M +$7K +0.54% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $5.04M $1.25M +$158K +14.4% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 $4.88M $1.26M +$317K +33.8% 01 Oct 2020 31 Dec 2020 10-K 10 Mar 2022
Q3 2020 $4.56M $1.24M +$317K +34.5% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $4.25M $1.3M +$559K +76% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021
Q1 2020 $3.69M $1.1M +$656K +149% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q4 2019 $3.03M $938K 01 Oct 2019 31 Dec 2019 10-K 11 Mar 2021
Q3 2019 $918K 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 $736K 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 $439K 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020

Galera Therapeutics, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 -$11.4M -100% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 $11.4M -$157K -1.36% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 $11.6M +$4.38M +60.8% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $7.19M +$2.31M +47.4% 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2023
2020 $4.88M +$1.85M +61% 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022
2019 $3.03M +$2.81M +1278% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021
2018 $220K 01 Jan 2018 31 Dec 2018 10-K 10 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.